Clinicians should be vigilant about cardiovascular side effects with ADHD medications but not avoid using them, experts say.

ADHD medications raise heart rate and blood pressure meaning wider cardiovascular monitoring across all treatments is required.

Elite Pharmaceuticals announced the launch of its generic version of Vyvanse® (Lisdexamfetamine Disylate) in various strengths, targeting the ADHD treatment market. The product, which is marketed ...

today announced that the company has launched Elite's generic version of Vyvanse® (Lisdexamfetamine Disylate) with strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg capsules.

Shionogi is an established player in the Japanese ADHD market with Vyvanse (lisdexamfetamine dimesylate), one of the only stimulant drugs approved for use by the MHLW- although, since 2020 ...

However, it is known that other manufacturers have struggled, with Takeda also citing ‘manufacturing delays’ for the shortage of its Vyvanse (lisdexamfetamine) ADHD drug. The actual process ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation.